Refine
Document Type
Is part of the Bibliography
- no (42)
Keywords
- Diagnose (12)
- Artificial Intelligence (10)
- Deep Learning (10)
- Künstliche Intelligenz (10)
- Maschinelles Lernen (10)
- Speiseröhrenkrebs (7)
- Machine learning (6)
- Speiseröhrenkrankheit (6)
- Adenocarcinoma (5)
- Barrett's esophagus (5)
Institute
Begutachtungsstatus
- peer-reviewed (34)
We investigate contrastive learning in a multi-task learning setting classifying and segmenting early Barrett’s cancer. How can contrastive learning be applied in a domain with few classes and low inter-class and inter-sample variance, potentially enabling image retrieval or image attribution? We introduce a data sampling strategy that mines per-lesion data for positive samples and keeps a queue of the recent projections as negative samples. We propose a masking strategy for the NT-Xent loss that keeps the negative set pure and removes samples from the same lesion. We show cohesion and uniqueness improvements of the proposed method in feature space. The introduction of the auxiliary objective does not affect the performance but adds the ability to indicate similarity between lesions. Therefore, the approach could enable downstream auto-documentation tasks on homogeneous medical image data.
Clinical setting
Third space procedures such as endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM) are complex minimally invasive techniques with an elevated risk for operator-dependent adverse events such as bleeding and perforation. This risk arises from accidental dissection into the muscle layer or through submucosal blood vessels as the submucosal cutting plane within the expanding resection site is not always apparent. Deep learning algorithms have shown considerable potential for the detection and characterization of gastrointestinal lesions. So-called AI – clinical decision support solutions (AI-CDSS) are commercially available for polyp detection during colonoscopy. Until now, these computer programs have concentrated on diagnostics whereas an AI-CDSS for interventional endoscopy has not yet been introduced. We aimed to develop an AI-CDSS („Smart ESD“) for real-time intra-procedural detection and delineation of blood vessels, tissue structures and endoscopic instruments during third-space endoscopic procedures.
Characteristics of Smart ESD
An AI-CDSS was invented that delineates blood vessels, tissue structures and endoscopic instruments during third-space endoscopy in real-time. The output can be displayed by an overlay over the endoscopic image with different modes of visualization, such as a color-coded semitransparent area overlay, or border tracing (demonstration video). Hereby the optimal layer for dissection can be visualized, which is close above or directly at the muscle layer, depending on the applied technique (ESD or POEM). Furthermore, relevant blood vessels (thickness> 1mm) are delineated. Spatial proximity between the electrosurgical knife and a blood vessel triggers a warning signal. By this guidance system, inadvertent dissection through blood vessels could be averted.
Technical specifications
A DeepLabv3+ neural network architecture with KSAC and a 101-layer ResNeSt backbone was used for the development of Smart ESD. It was trained and validated with 2565 annotated still images from 27 full length third-space endoscopic videos. The annotation classes were blood vessel, submucosal layer, muscle layer, electrosurgical knife and endoscopic instrument shaft. A test on a separate data set yielded an intersection over union (IoU) of 68%, a Dice Score of 80% and a pixel accuracy of 87%, demonstrating a high overlap between expert and AI segmentation. Further experiments on standardized video clips showed a mean vessel detection rate (VDR) of 85% with values of 92%, 70% and 95% for POEM, rectal ESD and esophageal ESD respectively. False positive measurements occurred 0.75 times per minute. 7 out of 9 vessels which caused intraprocedural bleeding were caught by the algorithm, as well as both vessels which required hemostasis via hemostatic forceps.
Future perspectives
Smart ESD performed well for vessel and tissue detection and delineation on still images, as well as on video clips. During a live demonstration in the endoscopy suite, clinical applicability of the innovation was examined. The lag time for processing of the live endoscopic image was too short to be visually detectable for the interventionist. Even though the algorithm could not be applied during actual dissection by the interventionist, Smart ESD appeared readily deployable during visual assessment by ESD experts. Therefore, we plan to conduct a clinical trial in order to obtain CE-certification of the algorithm. This new technology may improve procedural safety and speed, as well as training of modern minimally invasive endoscopic resection techniques.
Aims
Human-computer interactions (HCI) may have a relevant impact on the performance of Artificial Intelligence (AI). Studies show that although endoscopists assessing Barrett’s esophagus (BE) with AI improve their performance significantly, they do not achieve the level of the stand-alone performance of AI. One aspect of HCI is the impact of AI on the degree of certainty and confidence displayed by the endoscopist. Indirectly, diagnostic confidence when using AI may be linked to trust and acceptance of AI. In a BE video study, we aimed to understand the impact of AI on the diagnostic confidence of endoscopists and the possible correlation with diagnostic performance.
Methods
22 endoscopists from 12 centers with varying levels of BE experience reviewed ninety-six standardized endoscopy videos. Endoscopists were categorized into experts and non-experts and randomly assigned to assess the videos with and without AI. Participants were randomized in two arms: Arm A assessed videos first without AI and then with AI, while Arm B assessed videos in the opposite order. Evaluators were tasked with identifying BE-related neoplasia and rating their confidence with and without AI on a scale from 0 to 9.
Results
The utilization of AI in Arm A (without AI first, with AI second) significantly elevated confidence levels for experts and non-experts (7.1 to 8.0 and 6.1 to 6.6, respectively). Only non-experts benefitted from AI with a significant increase in accuracy (68.6% to 75.5%). Interestingly, while the confidence levels of experts without AI were higher than those of non-experts with AI, there was no significant difference in accuracy between these two groups (71.3% vs. 75.5%). In Arm B (with AI first, without AI second), experts and non-experts experienced a significant reduction in confidence (7.6 to 7.1 and 6.4 to 6.2, respectively), while maintaining consistent accuracy levels (71.8% to 71.8% and 67.5% to 67.1%, respectively).
Conclusions
AI significantly enhanced confidence levels for both expert and non-expert endoscopists. Endoscopists felt significantly more uncertain in their assessments without AI. Furthermore, experts with or without AI consistently displayed higher confidence levels than non-experts with AI, irrespective of comparable outcomes. These findings underscore the possible role of AI in improving diagnostic confidence during endoscopic assessment.
Aims
Barrett´s esophagus related neoplasia (BERN) is difficult to detect and characterize during endoscopy, even for expert endoscopists. We aimed to assess the add-on effect of an Artificial Intelligence (AI) algorithm (Barrett-Ampel) as a decision support system (DSS) for non-expert endoscopists in the evaluation of Barrett’s esophagus (BE) and BERN.
Methods
Twelve videos with multimodal imaging white light (WL), narrow-band imaging (NBI), texture and color enhanced imaging (TXI) of histologically confirmed BE and BERN were assessed by expert and non-expert endoscopists. For each video, endoscopists were asked to identify the area of BERN and decide on the biopsy spot. Videos were assessed by the AI algorithm and regions of BERN were highlighted in real-time by a transparent overlay. Finally, endoscopists were shown the AI videos and asked to either confirm or change their initial decision based on the AI support.
Results
Barrett-Ampel correctly identified all areas of BERN, irrespective of the imaging modality (WL, NBI, TXI), but misinterpreted two inflammatory lesions (Accuracy=75%). Expert endoscopists had a similar performance (Accuracy=70,8%), while non-experts had an accuracy of 58.3%. When AI was implemented as a DSS, non-expert endoscopists improved their diagnostic accuracy to 75%.
Conclusions
AI may have the potential to support non-expert endoscopists in the assessment of videos of BE and BERN. Limitations of this study include the low number of videos used. Randomized clinical trials in a real-life setting should be performed to confirm these results.
Effect of AI on performance of endoscopists to detect Barrett neoplasia: A Randomized Tandem Trial
()
Background and study aims
To evaluate the effect of an AI-based clinical decision support system (AI) on the performance and diagnostic confidence of endoscopists during the assessment of Barrett's esophagus (BE).
Patients and Methods
Ninety-six standardized endoscopy videos were assessed by 22 endoscopists from 12 different centers with varying degrees of BE experience.
The assessment was randomized into two video sets: Group A (review first without AI and second with AI) and group B (review first with AI and second without AI). Endoscopists were required to evaluate each video for the presence of Barrett's esophagus-related neoplasia (BERN) and then decide on a spot for a targeted biopsy. After the second assessment, they were allowed to change their clinical decision and confidence level.
Results
AI had a standalone sensitivity, specificity, and accuracy of 92.2%, 68.9%, and 81.6%, respectively. Without AI, BE experts had an overall sensitivity, specificity, and accuracy of 83.3%, 58.1 and 71.5%, respectively. With AI, BE nonexperts showed a significant improvement in sensitivity and specificity when videos were assessed a second time with AI (sensitivity 69.7% (95% CI, 65.2% - 74.2%) to 78.0% (95% CI, 74.0% - 82.0%); specificity 67.3% (95% CI, 62.5% - 72.2%) to 72.7% (95 CI, 68.2% - 77.3%). In addition, the diagnostic confidence of BE nonexperts improved significantly with AI.
Conclusion
BE nonexperts benefitted significantly from the additional AI. BE experts and nonexperts remained below the standalone performance of AI, suggesting that there may be other factors influencing endoscopists to follow or discard AI advice.
ARTIFICIAL INTELLIGENCE (AI) – ASSISTED VESSEL AND TISSUE RECOGNITION IN THIRD-SPACE ENDOSCOPY
(2022)
Aims
Third-space endoscopy procedures such as endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM) are complex interventions with elevated risk of operator-dependent adverse events, such as intra-procedural bleeding and perforation. We aimed to design an artificial intelligence clinical decision support solution (AI-CDSS, “Smart ESD”) for the detection and delineation of vessels, tissue structures, and instruments during third-space endoscopy procedures.
Methods
Twelve full-length third-space endoscopy videos were extracted from the Augsburg University Hospital database. 1686 frames were annotated for the following categories: Submucosal layer, blood vessels, electrosurgical knife and endoscopic instrument. A DeepLabv3+neural network with a 101-layer ResNet backbone was trained and validated internally. Finally, the ability of the AI system to detect visible vessels during ESD and POEM was determined on 24 separate video clips of 7 to 46 seconds duration and showing 33 predefined vessels. These video clips were also assessed by an expert in third-space endoscopy.
Results
Smart ESD showed a vessel detection rate (VDR) of 93.94%, while an average of 1.87 false positive signals were recorded per minute. VDR of the expert endoscopist was 90.1% with no false positive findings. On the internal validation data set using still images, the AI system demonstrated an Intersection over Union (IoU), mean Dice score and pixel accuracy of 63.47%, 76.18% and 86.61%, respectively.
Conclusions
This is the first AI-CDSS aiming to mitigate operator-dependent limitations during third-space endoscopy. Further clinical trials are underway to better understand the role of AI in such procedures.
The endoscopic features associated with eosinophilic esophagitis (EoE) may be missed during routine endoscopy. We aimed to develop and evaluate an Artificial Intelligence (AI) algorithm for detecting and quantifying the endoscopic features of EoE in white light images, supplemented by the EoE Endoscopic Reference Score (EREFS). An AI algorithm (AI-EoE) was constructed and trained to differentiate between EoE and normal esophagus using endoscopic white light images extracted from the database of the University Hospital Augsburg. In addition to binary classification, a second algorithm was trained with specific auxiliary branches for each EREFS feature (AI-EoE-EREFS). The AI algorithms were evaluated on an external data set from the University of North Carolina, Chapel Hill (UNC), and compared with the performance of human endoscopists with varying levels of experience. The overall sensitivity, specificity, and accuracy of AI-EoE were 0.93 for all measures, while the AUC was 0.986. With additional auxiliary branches for the EREFS categories, the AI algorithm (AI-EoEEREFS) performance improved to 0.96, 0.94, 0.95, and 0.992 for sensitivity, specificity, accuracy, and AUC, respectively. AI-EoE and AI-EoE-EREFS performed significantly better than endoscopy beginners and senior fellows on the same set of images. An AI algorithm can be trained to detect and quantify endoscopic features of EoE with excellent performance scores. The addition of the EREFS criteria improved the performance of the AI algorithm, which performed significantly better than endoscopists with a lower or medium experience level.
Aims
Eosinophilic esophagitis (EoE) is easily missed during endoscopy, either because physicians are not familiar with its endoscopic features or the morphologic changes are too subtle. In this preliminary paper, we present the first attempt to detect EoE in endoscopic white light (WL) images using a deep learning network (EoE-AI).
Methods
401 WL images of eosinophilic esophagitis and 871 WL images of normal esophageal mucosa were evaluated. All images were assessed for the Endoscopic Reference score (EREFS) (edema, rings, exudates, furrows, strictures). Images with strictures were excluded. EoE was defined as the presence of at least 15 eosinophils per high power field on biopsy. A convolutional neural network based on the ResNet architecture with several five-fold cross-validation runs was used. Adding auxiliary EREFS-classification branches to the neural network allowed the inclusion of the scores as optimization criteria during training. EoE-AI was evaluated for sensitivity, specificity, and F1-score. In addition, two human endoscopists evaluated the images.
Results
EoE-AI showed a mean sensitivity, specificity, and F1 of 0.759, 0.976, and 0.834 respectively, averaged over the five distinct cross-validation runs. With the EREFS-augmented architecture, a mean sensitivity, specificity, and F1-score of 0.848, 0.945, and 0.861 could be demonstrated respectively. In comparison, the two human endoscopists had an average sensitivity, specificity, and F1-score of 0.718, 0.958, and 0.793.
Conclusions
To the best of our knowledge, this is the first application of deep learning to endoscopic images of EoE which were also assessed after augmentation with the EREFS-score. The next step is the evaluation of EoE-AI using an external dataset. We then plan to assess the EoE-AI tool on endoscopic videos, and also in real-time. This preliminary work is encouraging regarding the ability for AI to enhance physician detection of EoE, and potentially to do a true “optical biopsy” but more work is needed.
Aims
Celiac disease (CD) is a complex condition caused by an autoimmune reaction to ingested gluten. Due to its polymorphic manifestation and subtle endoscopic presentation, the diagnosis is difficult and thus the disorder is underreported. We aimed to use deep learning to identify celiac disease on endoscopic images of the small bowel.
Methods
Patients with small intestinal histology compatible with CD (MARSH classification I-III) were extracted retrospectively from the database of Augsburg University hospital. They were compared to patients with no clinical signs of CD and histologically normal small intestinal mucosa. In a first step MARSH III and normal small intestinal mucosa were differentiated with the help of a deep learning algorithm. For this, the endoscopic white light images were divided into five equal-sized subsets. We avoided splitting the images of one patient into several subsets. A ResNet-50 model was trained with the images from four subsets and then validated with the remaining subset. This process was repeated for each subset, such that each subset was validated once. Sensitivity, specificity, and harmonic mean (F1) of the algorithm were determined.
Results
The algorithm showed values of 0.83, 0.88, and 0.84 for sensitivity, specificity, and F1, respectively. Further data showing a comparison between the detection rate of the AI model and that of experienced endoscopists will be available at the time of the upcoming conference.
Conclusions
We present the first clinical report on the use of a deep learning algorithm for the detection of celiac disease using endoscopic images. Further evaluation on an external data set, as well as in the detection of CD in real-time, will follow. However, this work at least suggests that AI can assist endoscopists in the endoscopic diagnosis of CD, and ultimately may be able to do a true optical biopsy in live-time.
The early diagnosis of cancer in Barrett’s esophagus is crucial for improving the prognosis. However, identifying Barrett’s esophagus-related neoplasia (BERN) is challenging, even for experts [1]. Four-quadrant biopsies may improve the detection of neoplasia, but they can be associated with sampling errors. The application of artificial intelligence (AI) to the assessment of Barrett’s esophagus could improve the diagnosis of BERN, and this has been demonstrated in both preclinical and clinical studies [2] [3].
In this video demonstration, we show the accurate detection and delineation of BERN in two patients ([Video 1]). In part 1, the AI system detects a mucosal cancer about 20 mm in size and accurately delineates the lesion in both white-light and narrow-band imaging. In part 2, a small island of BERN with high-grade dysplasia is detected and delineated in white-light, narrow-band, and texture and color enhancement imaging. The video shows the results using a transparent overlay of the mucosal cancer in real time as well as a full segmentation preview. Additionally, the optical flow allows for the assessment of endoscope movement, something which is inversely related to the reliability of the AI prediction. We demonstrate that multimodal imaging can be applied to the AI-assisted detection and segmentation of even small focal lesions in real time.
Real-time computational speed and a high degree of precision are requirements for computer-assisted interventions. Applying a segmentation network to a medical video processing task can introduce significant inter-frame prediction noise. Existing approaches can reduce inconsistencies by including temporal information but often impose requirements on the architecture or dataset. This paper proposes a method to include temporal information in any segmentation model and, thus, a technique to improve video segmentation performance without alterations during training or additional labeling. With Motion-Corrected Moving Average, we refine the exponential moving average between the current and previous predictions. Using optical flow to estimate the movement between consecutive frames, we can shift the prior term in the moving-average calculation to align with the geometry of the current frame. The optical flow calculation does not require the output of the model and can therefore be performed in parallel, leading to no significant runtime penalty for our approach. We evaluate our approach on two publicly available segmentation datasets and two proprietary endoscopic datasets and show improvements over a baseline approach.
We propose an automatic approach for early detection of adenocarcinoma in the esophagus. High-definition endoscopic images (50 cancer, 50 Barrett) are partitioned into a dataset containing approximately equal amounts of patches showing cancerous and non-cancerous regions. A deep convolutional neural network is adapted to the data using a transfer learning approach. The final classification of an image is determined by at least one patch, for which the probability being a cancer patch exceeds a given threshold. The model was evaluated with leave one patient out cross-validation. With sensitivity and specificity of 0.94 and 0.88, respectively, our findings improve recently published results on the same image data base considerably. Furthermore, the visualization of the class probabilities of each individual patch indicates, that our approach might be extensible to the segmentation domain.
Celiac disease is an autoimmune disorder caused by gluten that results in an inflammatory response of the small intestine.We investigated whether celiac disease can be detected using endoscopic images through a deep learning approach. The results show that additional clinical parameters can improve the classification accuracy. In this work, we distinguished between healthy tissue and Marsh III, according to the Marsh score system. We first trained a baseline network to classify endoscopic images of the small bowel into these two classes and then augmented the approach with a multimodality component that took the antibody status into account.
Einleitung
Die sichere Detektion und Charakterisierung von Barrett-Ösophagus assoziierten Neoplasien (BERN) stellt selbst für erfahrene Endoskopiker eine Herausforderung dar.
Ziel
Ziel dieser Studie ist es, den Add-on Effekt eines künstlichen Intelligenz (KI) Systems (Barrett-Ampel) als Entscheidungsunterstüzungssystem für Endoskopiker ohne Expertise bei der Untersuchung von BERN zu evaluieren.
Material und Methodik
Zwölf Videos in „Weißlicht“ (WL), „narrow-band imaging“ (NBI) und „texture and color enhanced imaging“ (TXI) von histologisch bestätigten Barrett-Metaplasien oder BERN wurden von Experten und Untersuchern ohne Barrett-Expertise evaluiert. Die Probanden wurden dazu aufgefordert in den Videos auftauchende BERN zu identifizieren und gegebenenfalls die optimale Biopsiestelle zu markieren. Unser KI-System wurde demselben Test unterzogen, wobei dieses BERN in Echtzeit segmentierte und farblich von umliegendem Epithel differenzierte. Anschließend wurden den Probanden die Videos mit zusätzlicher KI-Unterstützung gezeigt. Basierend auf dieser neuen Information, wurden die Probanden zu einer Reevaluation ihrer initialen Beurteilung aufgefordert.
Ergebnisse
Die „Barrett-Ampel“ identifizierte unabhängig von den verwendeten Darstellungsmodi (WL, NBI, TXI) alle BERN. Zwei entzündlich veränderte Läsionen wurden fehlinterpretiert (Genauigkeit=75%). Während Experten vergleichbare Ergebnisse erzielten (Genauigkeit=70,8%), hatten Endoskopiker ohne Expertise bei der Beurteilung von Barrett-Metaplasien eine Genauigkeit von lediglich 58,3%. Wurden die nicht-Experten allerdings von unserem KI-System unterstützt, erreichten diese eine Genauigkeit von 75%.
Zusammenfassung
Unser KI-System hat das Potential als Entscheidungsunterstützungssystem bei der Differenzierung zwischen Barrett-Metaplasie und BERN zu fungieren und so Endoskopiker ohne entsprechende Expertise zu assistieren. Eine Limitation dieser Studie ist die niedrige Anzahl an eingeschlossenen Videos. Um die Ergebnisse dieser Studie zu bestätigen, müssen randomisierte kontrollierte klinische Studien durchgeführt werden.
Einleitung
Third-Space Interventionen wie die endoskopische Submukosadissektion (ESD) und die perorale endoskopische Myotomie (POEM) sind technisch anspruchsvoll und mit einem erhöhten Risiko für intraprozedurale Komplikationen wie Blutung oder Perforation assoziiert. Moderne Computerprogramme zur Unterstützung bei diagnostischen Entscheidungen werden unter Einsatz von künstlicher Intelligenz (KI) in der Endoskopie bereits erfolgreich eingesetzt. Ziel der vorliegenden Arbeit war es, relevante anatomische Strukturen mithilfe eines Deep-Learning Algorithmus zu detektieren und segmentieren, um die Sicherheit und Anwendbarkeit von ESD und POEM zu erhöhen.
Methoden
Zwölf Videoaufnahmen in voller Länge von Third-Space Endoskopien wurden aus der Datenbank des Universitätsklinikums Augsburg extrahiert. 1686 Einzelbilder wurden für die Kategorien Submukosa, Blutgefäß, Dissektionsmesser und endoskopisches Instrument annotiert und segmentiert. Mit diesem Datensatz wurde ein DeepLabv3+neuronales Netzwerk auf der Basis eines ResNet mit 101 Schichten trainiert und intern anhand der Parameter Intersection over Union (IoU), Dice Score und Pixel Accuracy validiert. Die Fähigkeit des Algorithmus zur Gefäßdetektion wurde anhand von 24 Videoclips mit einer Spieldauer von 7 bis 46 Sekunden mit 33 vordefinierten Gefäßen evaluiert. Anhand dieses Tests wurde auch die Gefäßdetektionsrate eines Experten in der Third-Space Endoskopie ermittelt.
Ergebnisse
Der Algorithmus zeigte eine Gefäßdetektionsrate von 93,94% mit einer mittleren Rate an falsch positiven Signalen von 1,87 pro Minute. Die Gefäßdetektionsrate des Experten lag bei 90,1% ohne falsch positive Ergebnisse. In der internen Validierung an Einzelbildern wurde eine IoU von 63,47%, ein mittlerer Dice Score von 76,18% und eine Pixel Accuracy von 86,61% ermittelt.
Zusammenfassung
Dies ist der erste KI-Algorithmus, der für den Einsatz in der therapeutischen Endoskopie entwickelt wurde. Präliminäre Ergebnisse deuten auf eine mit Experten vergleichbare Detektion von Gefäßen während der Untersuchung hin. Weitere Untersuchungen sind nötig, um die Leistung des Algorithmus im Vergleich zum Experten genauer zu eruieren sowie einen möglichen klinischen Nutzen zu ermitteln.
Introduction
We present a clinical case showing the real-time detection, characterization and delineation of an early Barrett’s cancer using AI.
Patients and methods
A 70-year old patient with a long-segment Barrett’s esophagus (C5M7) was assessed with an AI algorithm.
Results
The AI system detected a 10 mm focal lesion and AI characterization predicted cancer with a probability of >90%. After ESD resection, histopathology showed mucosal adenocarcinoma (T1a (m), R0) confirming AI diagnosis.
Conclusion
We demonstrate the real-time AI detection, characterization and delineation of a small and early mucosal Barrett’s cancer.
In 2015 we began a sub-challenge at the EndoVis workshop at MICCAI in Munich using endoscope images of exvivo tissue with automatically generated annotations from robot forward kinematics and instrument CAD models. However, the limited background variation and simple motion rendered the dataset uninformative in learning about which techniques would be suitable for segmentation in real surgery. In 2017, at the same workshop in Quebec we introduced the robotic instrument segmentation dataset with 10 teams participating in the challenge to perform binary, articulating parts and type segmentation of da Vinci instruments. This challenge included realistic instrument motion and more complex porcine tissue as background and was widely addressed with modfications on U-Nets and other popular CNN architectures [1].
In 2018 we added to the complexity by introducing a set of anatomical objects and medical devices to the segmented classes. To avoid over-complicating the challenge, we continued with porcine data which is dramatically simpler than human tissue due to the lack of fatty tissue occluding many organs.
Einleitung
Die Differenzierung zwischen nicht dysplastischem Barrett-Ösophagus (NDBE) und mit Barrett-Ösophagus assoziierten Neoplasien (BERN) während der endoskopischen Inspektion erfordert viel Expertise. Die frühe Diagnosestellung ist wichtig für die weitere Prognose des Barrett-Karzinoms. In Deutschland werden Patient:innen mit einem Barrett-Ösophagus (BE) in der Regel im niedergelassenen Sektor überwacht.
Ziele
Ziel ist es, den Einfluss von einem auf Künstlicher Intelligenz (KI) basierenden klinischen Entscheidungsunterstützungssystems (CDSS) auf die Performance von niedergelassenen Gastroenterolog:innen (NG) bei der Evaluation von Barrett-Ösophagus (BE) zu untersuchen.
Methodik
Es erfolgte die prospektive Sammlung von 96 unveränderten hochauflösenden Videos mit Fällen von Patient:innen mit histologisch bestätigtem NDBE und BERN. Alle eingeschlossenen Fälle enthielten mindestens zwei der folgenden Darstellungsmethoden: HD-Weißlichtendoskopie, Narrow Band Imaging oder Texture and Color Enhancement Imaging. Sechs NG von sechs unterschiedlichen Praxen wurden als Proband:innen eingeschlossen. Es erfolgte eine permutierte Block-Randomisierung der Videofälle in entweder Gruppe A oder Gruppe B. Gruppe A implizierte eine Evaluation des Falls durch Proband:innen zunächst ohne KI und anschließend mit KI als CDSS. In Gruppe B erfolgte die Evaluation in umgekehrter Reihenfolge. Anschließend erfolgte eine zufällige Wiedergabe der so entstandenen Subgruppen im Rahmen des Tests.
Ergebnis
In diesem Test konnte ein von uns entwickeltes KI-System (Barrett-Ampel) eine Sensitivität von 92,2%, eine Spezifität von 68,9% und eine Accuracy von 81,3% erreichen. Mit der Hilfe von KI verbesserte sich die Sensitivität der NG von 64,1% auf 71,2% (p<0,001) und die Accuracy von 66,3% auf 70,8% (p=0,006) signifikant. Eine signifikante Verbesserung dieser Parameter zeigte sich ebenfalls, wenn die Proband:innen die Fälle zunächst ohne KI evaluierten (Gruppe A). Wurde der Fall jedoch als Erstes mit der Hilfe von KI evaluiert (Gruppe B), blieb die Performance nahezu konstant.
Schlussfolgerung
Es konnte ein performantes KI-System zur Evaluation von BE entwickelt werden. NG verbessern sich bei der Evaluation von BE durch den Einsatz von KI.
Einleitung
Third space Endoskopieprozeduren wie die endoskopische Submukosadissektion (ESD) und die perorale endoskopische Myotomie (POEM) sind technisch anspruchsvoll und gehen mit untersucherabhängigen Komplikationen wie Blutungen und Perforationen einher. Grund hierfür ist die unabsichtliche Durchschneidung von submukosalen Blutgefäßen ohne präemptive Koagulation.
Ziele
Die Forschungsfrage, ob ein KI-Algorithmus die intraprozedurale Gefäßerkennung bei ESD und POEM unterstützen und damit Komplikationen wie Blutungen verhindern könnte, erscheint in Anbetracht des erfolgreichen Einsatzes von KI bei der Erkennung von Kolonpolypen interessant.
Methoden
Auf 5470 Einzelbildern von 59 third space Endoscopievideos wurden submukosale Blutgefäße annotiert. Zusammen mit weiteren 179.681 nicht-annotierten Bildern wurde ein DeepLabv3+neuronales Netzwerk mit dem ECMT-Verfahren für semi-supervised learning trainiert, um Blutgefäße in Echtzeit erkennen zu können. Für die Evaluation wurde ein Videotest mit 101 Videoclips aus 15 vom Trainingsdatensatz separaten Prozeduren mit 200 vordefinierten Gefäßen erstellt. Die Gefäßdetektionsrate, -zeit und -dauer, definiert als der Prozentsatz an Einzelbildern eines Videos bezogen auf den Goldstandard, auf denen ein definiertes Gefäß erkannt wurde, wurden erhoben. Acht erfahrene Endoskopiker wurden mithilfe dieses Videotests im Hinblick auf Gefäßdetektion getestet, wobei eine Hälfte der Videos nativ, die andere Hälfte nach Markierung durch den KI-Algorithmus angesehen wurde.
Ergebnisse
Der mittlere Dice Score des Algorithmus für Blutgefäße war 68%. Die mittlere Gefäßdetektionsrate im Videotest lag bei 94% (96% für ESD; 74% für POEM). Die mediane Gefäßdetektionszeit des Algorithmus lag bei 0,32 Sekunden (0,3 Sekunden für ESD; 0,62 Sekunden für POEM). Die mittlere Gefäßdetektionsdauer lag bei 59,1% (60,6% für ESD; 44,8% für POEM) des Goldstandards. Alle Endoskopiker hatten mit KI-Unterstützung eine höhere Gefäßdetektionsrate als ohne KI. Die mittlere Gefäßdetektionsrate ohne KI lag bei 56,4%, mit KI bei 71,2% (p<0.001).
Schlussfolgerung
KI-Unterstützung war mit einer statistisch signifikant höheren Gefäßdetektionsrate vergesellschaftet. Die mediane Gefäßdetektionszeit von deutlich unter einer Sekunde sowie eine Gefäßdetektionsdauer von größer 50% des Goldstandards wurden für den klinischen Einsatz als ausreichend erachtet. In prospektiven Anwendungsstudien sollte der KI-Algorithmus auf klinische Relevanz getestet werden.
Barrett-Ampel
(2022)
Hintergrund
Adenokarzinome des Ösophagus sind bis heute mit einer infausten Prognose vergesellschaftet (1). Obwohl Endoskopiker mit Barrett-Ösophagus als Präkanzerose konfrontiert werden, ist vor allem für nicht-Experten die Differenzierung zwischen Barrett-Ösophagus ohne Dysplasie und assoziierten Neoplasien mitunter schwierig. Existierende Biopsieprotokolle (z.B. Seattle Protokoll) sind oftmals unzuverlässig (2). Eine frühzeitige Diagnose des Adenokarzinoms ist allerdings von fundamentaler Bedeutung für die Prognose des Patienten.
Forschungsansatz
Auf der Grundlage dieser Problematik, entwickelten wir in Kooperation mit dem Forschungslabor „Regensburg Medical Image Computing (ReMIC)“ der OTH Regensburg ein auf künstlicher Intelligenz (KI) basiertes Entscheidungsunterstützungssystem (CDSS). Das auf einer DeepLabv3+ neuronalen Netzwerkarchitektur basierende CDSS differenziert mittels Mustererkennung Barrett- Ösophagus ohne Dysplasie von Barrett-Ösophagus mit Dysplasie bzw. Neoplasie („Klassifizierung“). Hierbei werden gemittelte Ausgabewahrscheinlichkeiten mit einem vom Benutzer definierten Schwellenwert verglichen. Für Vorhersagen, die den Schwellenwert überschreiten, berechnen wir die Kontur der Region und die Fläche. Sobald die vorhergesagte Läsion eine bestimmte Größe in der Eingabe überschreitet, heben wir sie und ihren Umriss hervor. So ermöglicht eine farbkodierte Visualisierung eine Abgrenzung zwischen Dysplasie bzw. Neoplasie und normalem Barrett-Epithel („Segmentierung“).
In einer Studie an Bildern in „Weißlicht“ (WL) und „Narrow Band Imaging“ (NBI) demonstrierten wir eine Sensitivität von mehr als 90% und eine Spezifität von mehr als 80% (3). In einem nächsten Schritt, differenzierte unser KI-Algorithmus Barrett- Metaplasien von assoziierten Neoplasien anhand von zufällig abgegriffenen Bildern in Echtzeit mit einer Accuracy von 89.9% (4). Darauf folgend, entwickelten wir unser System dahingehend weiter, dass unser Algorithmus nun auch dazu in der Lage ist, Untersuchungsvideos in WL, NBI und „Texture and Color Enhancement Imaging“ (TXI) in Echtzeit zu analysieren (5).
Aktuell führen wir eine Studie in einem randomisiert-kontrollierten Ansatz an unveränderten Untersuchungsvideos in WL, NBI und TXI durch.
Ausblick
Um Patienten mit aus Barrett-Metaplasien resultierenden Neoplasien frühestmöglich an „High-Volume“-Zentren überweisen zu können, soll unser KI-Algorithmus zukünftig vor allem Endoskopiker ohne extensive Erfahrung bei der Beurteilung von Barrett- Ösophagus in der Krebsfrüherkennung unterstützen.